IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,969,023 | -44.1% | 2,518,527 | -33.5% | 0.90% | -40.7% |
| Q2 2023 | $71,458,765 | +136.9% | 3,786,898 | -51.8% | 1.52% | +99.6% |
| Q1 2023 | $30,168,611 | -11.6% | 7,856,409 | +14.2% | 0.76% | -5.6% |
| Q4 2022 | $34,119,557 | +100.9% | 6,878,943 | +93.6% | 0.81% | +111.0% |
| Q3 2022 | $16,984,000 | +36.4% | 3,553,128 | +28.4% | 0.38% | +24.8% |
| Q2 2022 | $12,449,000 | – | 2,766,474 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |